{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:40:54Z","timestamp":1776883254735,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41433-024-03572-6","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T06:16:26Z","timestamp":1735280186000},"page":"1153-1159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enrolment characteristics in age-related macular degeneration clinical trials: a cross-sectional study"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-3162","authenticated-orcid":false,"given":"Brendan K.","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim S.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawaaz","family":"Nathoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-Ching","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo V.","family":"Navajas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Muni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-6599","authenticated-orcid":false,"given":"Radha P.","family":"Kohly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"3572_CR1","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728\u201338.","journal-title":"Lancet"},{"key":"3572_CR2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41433-019-0393-3","volume":"33","author":"P More","year":"2019","unstructured":"More P, Almuhtaseb H, Smith D, Fraser S, Lotery AJ. Socio-economic status and outcomes for patients with age-related macular degeneration. Eye. 2019;33:1224\u201331.","journal-title":"Eye"},{"key":"3572_CR3","doi-asserted-by":"crossref","unstructured":"Shughoury A, Sevgi DD, Ciulla TA. Molecular genetic mechanisms in age-related macular degeneration. Genes. 2022;13:1233.","DOI":"10.3390\/genes13071233"},{"key":"3572_CR4","doi-asserted-by":"crossref","unstructured":"Yuk J-S, Hwang JH. Menopause and the risk of developing age-related macular degeneration in Korean women. J Clin Med. 2022;11:1899.","DOI":"10.3390\/jcm11071899"},{"key":"3572_CR5","doi-asserted-by":"crossref","DOI":"10.1186\/s40662-016-0063-5","volume":"3","author":"KL Pennington","year":"2016","unstructured":"Pennington KL, DeAngelis MM. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis. 2016;3:34.","journal-title":"Eye Vis"},{"key":"3572_CR6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bjophthalmol-2020-316820","volume":"105","author":"Z Miao","year":"2021","unstructured":"Miao Z, Pei-Chen D, Jing-Hong L, Xiao-Feng Z, Chen-Wei P. Geographic distributions of age-related macular degeneration incidence: a systematic review and meta-analysis. Br J Ophthalmol. 2021;105:1427.","journal-title":"Br J Ophthalmol"},{"key":"3572_CR7","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1167\/iovs.07-1584","volume":"49","author":"MA Chang","year":"2008","unstructured":"Chang MA, Bressler SB, Munoz B, West SK. Racial differences and other risk factors for incidence and progression of age-related macular degeneration: Salisbury Eye Evaluation (SEE) Project. Invest Ophthalmol Vis Sci. 2008;49:2395\u2013402.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3572_CR8","doi-asserted-by":"crossref","DOI":"10.1186\/s13293-021-00401-3","volume":"12","author":"IO Aninye","year":"2021","unstructured":"Aninye IO, Digre K, Hartnett ME, Baldonado K, Shriver EM, Periman LM, et al. The roles of sex and gender in women\u2019s eye health disparities in the United States. Biol Sex Differ. 2021;12:57.","journal-title":"Biol Sex Differ"},{"key":"3572_CR9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/1120672120927256","volume":"31","author":"X Lin","year":"2020","unstructured":"Lin X, Lou L, Miao Q, Wang Y, Jin K, Shan P, et al. The pattern and gender disparity in global burden of age-related macular degeneration. Eur J Ophthalmol. 2020;31:1161\u201370.","journal-title":"Eur J Ophthalmol"},{"key":"3572_CR10","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1038\/s41433-023-02621-w","volume":"37","author":"BK Tao","year":"2023","unstructured":"Tao BK, Vosoughi AR, He B, Ling J, Xia M, Rocha G, et al. Representational disparity of sex, race, and ethnicity in presbyopia clinical trials: a cross-sectional study. Eye. 2023;37:3871\u20133.","journal-title":"Eye"},{"key":"3572_CR11","doi-asserted-by":"crossref","unstructured":"Tao B, Xie J, Xia M, Marzban S, Vosoughi A, Ahuja N, et al. Diversity in enrollment to clinical trials for cataract medicine and surgery: a meta-analysis. J Cataract Refract Surg. 2024;50:460\u20137.","DOI":"10.1097\/j.jcrs.0000000000001395"},{"key":"3572_CR12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jamaophthalmol.2021.0857","volume":"139","author":"ST Berkowitz","year":"2021","unstructured":"Berkowitz ST, Groth SL, Gangaputra S, Patel S. Racial\/ethnic disparities in ophthalmology clinical trials resulting in US Food and Drug Administration Drug Approvals from 2000 to 2020. JAMA Ophthalmol. 2021;139:629\u201337.","journal-title":"JAMA Ophthalmol"},{"key":"3572_CR13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.oret.2022.01.018","volume":"6","author":"T Bowe","year":"2022","unstructured":"Bowe T, Salabati M, Soares RR, Huang C, Singh RP, Khan MA, et al. Racial, ethnic, and gender disparities in diabetic macular edema clinical trials. Ophthalmol Retin. 2022;6:531\u20133.","journal-title":"Ophthalmol Retin"},{"key":"3572_CR14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet"},{"key":"3572_CR15","unstructured":"About the topic of race. United States Census Bureau; Suitland, Maryland, United States: 2023. https:\/\/www.census.gov\/topics\/population\/race\/about.html."},{"key":"3572_CR16","unstructured":"Blakeslee L, Caplan Z, Meyer JA, Rabe MA, Roberts AW. Age and sex composition: 2020. United States Census Buruea; Suitland, Maryland, United States: 2023. https:\/\/www.census.gov\/library\/publications\/2023\/decennial\/c2020br-06.html."},{"key":"3572_CR17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jamaoncol.2021.6968","volume":"8","author":"S Chen","year":"2022","unstructured":"Chen S, Li J, Shu M. Use of participation to prevalence ratio for evaluating the representation status of women in oncology clinical trials. JAMA Oncol. 2022;8:479\u201380.","journal-title":"JAMA Oncol"},{"key":"3572_CR18","unstructured":"Togioka BM, Duvivier D, Young E. Diversity and discrimination in healthcare. Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"3572_CR19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","volume":"44","author":"LT Clark","year":"2019","unstructured":"Clark LT, Watkins L, Pi\u00f1a IL, Elmer M, Akinboboye O, Gorham M, et al. Increasing diversity in clinical trials: overcoming critical barriers. Curr Probl Cardiol. 2019;44:148\u201372.","journal-title":"Curr Probl Cardiol"},{"key":"3572_CR20","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1056\/NEJMp2215609","volume":"388","author":"AL Schwartz","year":"2023","unstructured":"Schwartz AL, Alsan M, Morris AA, Halpern SD. Why diverse clinical trial participation matters. N Engl J Med. 2023;388:1252\u20134.","journal-title":"N Engl J Med"},{"key":"3572_CR21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-021-00316-8","volume":"7","author":"A Sharma","year":"2021","unstructured":"Sharma A, Palaniappan L. Improving diversity in medical research. Nat Rev Dis Prim. 2021;7:74.","journal-title":"Nat Rev Dis Prim"},{"key":"3572_CR22","first-page":"473","volume":"110","author":"FA Birnbaum","year":"2018","unstructured":"Birnbaum FA. Gender and ethnicity of enrolled participants in U.S. Food and Drug Administration (FDA) clinical trials for approved ophthalmological new molecular entities. J Natl Med Assoc. 2018;110:473\u20139.","journal-title":"J Natl Med Assoc"},{"key":"3572_CR23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamaophthalmol.2020.2107","volume":"138","author":"DB Moore","year":"2020","unstructured":"Moore DB. Reporting of race and ethnicity in the ophthalmology literature in 2019. JAMA Ophthalmol. 2020;138:903\u20136.","journal-title":"JAMA Ophthalmol"},{"key":"3572_CR24","unstructured":"QuickFacts. United States Census Bureau; 2023. https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045222."},{"key":"3572_CR25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ophtha.2005.12.013","volume":"113","author":"R Klein","year":"2006","unstructured":"Klein R, Klein BEK, Knudtson MD, Wong TY, Cotch MF, Liu K, et al. Prevalence of age-related macular degeneration in 4 racial\/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology. 2006;113:373\u201380.","journal-title":"Ophthalmology"},{"key":"3572_CR26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41433-018-0225-x","volume":"33","author":"Y Yanagi","year":"2019","unstructured":"Yanagi Y, Foo VHX, Yoshida A. Asian age-related macular degeneration: from basic science research perspective. Eye. 2019;33:34\u201349.","journal-title":"Eye"},{"key":"3572_CR27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ophtha.2015.12.026","volume":"123","author":"DE Fisher","year":"2016","unstructured":"Fisher DE, Klein BEK, Wong TY, Rotter JI, Li X, Shrager S, et al. Incidence of age-related macular degeneration in a multi-ethnic United States population: the Multi-Ethnic Study of Atherosclerosis. Ophthalmology. 2016;123:1297\u2013308.","journal-title":"Ophthalmology"},{"key":"3572_CR28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1001\/jamaophthalmol.2022.3929","volume":"140","author":"A-H Kaakour","year":"2022","unstructured":"Kaakour A-H, Hua H-U, Rachitskaya A. Representation of race and ethnicity in randomized clinical trials of diabetic macular edema and retinal vein occlusion compared to 2010 US Census Data. JAMA Ophthalmol. 2022;140:1096\u2013102.","journal-title":"JAMA Ophthalmol"},{"key":"3572_CR29","first-page":"123","volume":"114","author":"N Sanjiv","year":"2022","unstructured":"Sanjiv N, Osathanugrah P, Harrell M, Siegel NH, Ness S, Chen X, et al. Race and ethnic representation among clinical trials for diabetic retinopathy and diabetic macular edema within the United States: a review. J Natl Med Assoc. 2022;114:123\u201340.","journal-title":"J Natl Med Assoc"},{"key":"3572_CR30","doi-asserted-by":"crossref","first-page":"e218348","DOI":"10.1001\/jamanetworkopen.2021.8348","volume":"4","author":"K Allison","year":"2021","unstructured":"Allison K, Patel DG, Greene L. Racial and ethnic disparities in primary open-angle glaucoma clinical trials: a systematic review and meta-analysis. JAMA Netw Open. 2021;4:e218348.","journal-title":"JAMA Netw Open"},{"key":"3572_CR31","doi-asserted-by":"crossref","unstructured":"Yu AJ, Masalkhi M, Brown R, Chen B, Chhablani J. Racial and ethnic distribution in diabetic macular edema clinical trials in the United States (2002\u20132021). Ophthalmol Retina. 2023;7:1035\u201341.","DOI":"10.1016\/j.oret.2023.07.015"},{"key":"3572_CR32","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/archophthalmol.2011.163","volume":"129","author":"Y Murakami","year":"2011","unstructured":"Murakami Y, Lee BW, Duncan M, Kao A, Huang J-Y, Singh K, et al. Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population. Arch Ophthalmol. 2011;129:872\u20138.","journal-title":"Arch Ophthalmol"},{"key":"3572_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0039-6257(03)00028-6","volume":"48","author":"L Racette","year":"2003","unstructured":"Racette L, Wilson MR, Zangwill LM, Weinreb RN, Sample PA. Primary open-angle glaucoma in Blacks: a review. Surv Ophthalmol. 2003;48:295\u2013313.","journal-title":"Surv Ophthalmol"},{"key":"3572_CR34","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.oret.2018.05.005","volume":"2","author":"MA Mahr","year":"2018","unstructured":"Mahr MA, Hodge DO, Erie JC. Racial differences in age-related macular degeneration and associated anti\u2013vascular endothelial growth factor intravitreal injections among medicare beneficiaries. Ophthalmol Retin. 2018;2:1188\u201395.","journal-title":"Ophthalmol Retin"},{"key":"3572_CR35","unstructured":"Number of clinical trials by year, country, WHO region and income group (1999-2022). World Health Organization; Geneva, Switzerland: 2024. https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-clinical-trials-by-year-country-who-region-and-income-group."},{"key":"3572_CR36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","volume":"326","author":"A Flanagin","year":"2021","unstructured":"Flanagin A, Frey T, Christiansen SL. Committee AMAMoS. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA. 2021;326:621\u20137.","journal-title":"JAMA"},{"key":"3572_CR37","first-page":"238","volume":"404","author":"BK Tao","year":"2024","unstructured":"Tao BK, Xie JS, Kohly RP, Margolin E. Disease burden descriptions in trial protocols. Lancet. 2024;404:238\u20139.","journal-title":"Lancet"},{"key":"3572_CR38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4155\/cli.14.21","volume":"4","author":"E Seidler","year":"2014","unstructured":"Seidler E, Keshaviah A, Brown C, Wood E, Granick L, Kimball A. Geographic distribution of clinical trials may lead to inequities in access. Clin Investig. 2014;4:373\u201380.","journal-title":"Clin Investig"},{"key":"3572_CR39","unstructured":"clinicaltrials.gov. National Library of Medicine. Bethesda, Maryland, United States https:\/\/clinicaltrials.gov\/about-site\/about-ctg."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03572-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:03:05Z","timestamp":1744117385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03572-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3572"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03572-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Under article 2.4 of the Tri-Council Policy Statement, institutional review board approval was waived since all data were sources from published primary research and publicly available registries. No identifiable information was generated by this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}